ARCHIVES

In Brief: Top Priority: Keep Rauscher; Pay Raise Bill No Moving; Miller, Holland Head AACR, ASCO

This article is from The Cancer Letter archive.

Vol. 02 No. 21 | May 21, 1976

Download PDF Visit The Full Archive

Related Articles

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

June 11, 2014

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987

After a “humble” start at NCI, von Eschenbach set unachievable goal.

September 30, 2005

Scientists, Public Citizen Urge FDA To Ban Sale Of Obesity Drug Orlistat.

June 2, 2006

NCI Information Officer Plays Key Role In Cancer Program

February 8, 1980

NCCS Networker Volume 5 Issue 4, Fall 1991

September 13, 1991